%20(1)-808x422.webp)
Hubs
The Investment Landscape Hub
Powered by G-FINDER, this hub is your go-to resource for data and analysis on the funding landscape for global health R&D. This is where you'll find all the G-FINDER reports across neglected disease, emerging infectious diseases and sexual & reproductive health.

Hub Editors

Dr Paul Barnsley
Research and Analysis Lead

Dr Sabastine Wakdok
Director of Research
What is impacting global health?
Every year the G-FINDER project delivers the latest comprehensive data on global investment into R&D of new products to prevent, diagnose, control or cure diseases which kill millions. We analyse the funding landscape to show you where the money is coming from and where it's going. We reveal areas of growth, areas of decline and where we have gaps. We track which products have entered or moved along the pipeline thanks to this investment. This hub collates this huge resource of data and analysis in one place, where you can explore the findings and assess the implications.
The 2024 G-FINDER Neglected Disease R&D reportSpotlight on latest reports
Relied on by governments, NGOs, private and philanthropic funders, product developers and global health advocates worldwide to inform decisions on R&D funding.
%20(1)-808x422.webp)

G-FINDER 2024 Landscape of Emerging Infectious Disease Research & Development report: Lessons Learned

G-FINDER 2023 Sexual & Reproductive Health Research & Development report: Beyond Spillovers
Watch the launch of the Smart Decisions report
Online webinar held 30 January 2025
Watch the recording of the report launch event where we discuss tough choices that need to be made in global health R&D. Our guest speakers were George Jagoe from Medicines for Malaria Venture and Dr Bethan Hughes from Novartis who shared her personal opinions.
All resources in this hub
-404x303.webp)
10 min read
In turbulent times, Europe must double down on its investments in Global Health R&D
Vanessa Candeais shows how investment in global public goods, global solidarity, and equity is a strategic necessity for Europe, providing clarity and leadership for the world and for its own future.

%20(1)-404x211.webp)
10 min read
Smart Decisions launch event notes
We share the summary notes and slides from the launch of the Smart Decisions: the G-FINDER 2024 Neglected Disease R&D report


5 min read
Neglected disease funders
Who was funding what in 2023 and what does this mean for the future?


5 min read
Introduction
Start here for the 2024 G-FINDER Neglected Disease R&D report - entitled Smart Decisions.


5 min read
Discussion
Key messages from the 2023 global health R&D funding landscape and our recommendations for funders.


5 min read
Funding by disease
How much R&D funding for which diseases did we see in 2023?


10 min read
Enhancing global health policy-making with data: a look at G-FINDER and Compass
In this blog, our Chief Operating Officer, Anna Doubell, explains how we collect and curate the funding and pipeline data that drives decisions and informs policies in global health R&D.


45 min read
G-FINDER 2024 Landscape of Emerging Infectious Disease Research & Development report: Lessons Learned
This is our third report analysing global investment into research and development for emerging infectious diseases


45 min read
G-FINDER 2023 Neglected Disease Research & Development report: The Higher Cost of Lower Funding
This report contains an overview of the changes in neglected disease funding in 2022 and, for the first time, adds comprehensive coverage of the product pipeline in each disease area
